Department of Physiology, Harold Hamm Diabetes Center, The University of Oklahoma Health Science Center, Oklahoma City, United States ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

因此，迫切需要开发更有效的三阴性乳腺癌治疗方法。 2024年10月9日，哈佛大学医学院的研究人员在国际顶尖学术期刊 Nature 上发表了题为：AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution 的研究论文。 该研究表明，AKT抑制剂（AKTi）与EZH2抑制剂（EZH2i ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...

Deciding on antigen vs. antibody tests when choosing a COVID-19 test is easier when the definitions and their function are clear. These tests represent different ways you can check for SARS-CoV-2, the ...

Expert Rev Anticancer Ther. 2009;9(9):1305-1316. LY294002, a PI3K inhibitor, has been tested in vitro with lymphoma cell lines, and was shown to induce apoptosis. However, since this pathway is ...

Membrane-located SCP1 dephosphorylates AKT at serine 473, leading to the abolishment of serine 473 phosphorylation that results in suppressed angiogenesis and a decreased risk of tumorigenesis.